Genmab Newsroom

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsDec 2 21:32

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 29 21:31

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 26 21:32

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 25 23:33

Jefferies Sticks to Their Hold Rating for Genmab A/S (0MGB)

TipRanksNov 25 20:18

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 22 22:31

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 21 21:33

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 20 22:31

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 19 22:31

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 19 16:37

Truist Financial Maintains Genmab(GMAB.US) With Buy Rating

Futu NewsNov 19 16:37

Barclays Reaffirms Their Buy Rating on Genmab A/S (0MGB)

TipRanksNov 19 15:29

Genmab (GMAB) Gets a Buy From Truist Financial

TipRanksNov 18 20:19

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 15 21:33

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 14 21:35

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 13 21:37

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 11 21:37

Genmab Analyst Ratings

BenzingaNov 8 23:32

BMO Capital Reiterates Outperform on Genmab, Raises Price Target to $48

BenzingaNov 8 23:32

Morgan Stanley Maintains Genmab(GMAB.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 8 22:31